| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0008 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.097 | 0.0009 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | 0.49 | 0.001 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.001 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.097 | 0.002 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |